http://www.medpagetoday.com/Cardiology/Strokes/62947?
Group claims 'covert' brain damage is under-reported
Citing under-reporting of certain neurologic events, a group of U.S. and European researchers has published a consensus statement on new standardized neurological endpoints for cardiovascular clinical trials. The paper calls for classification of three types of brain damage to enable better reporting: overt CNS damage such as stroke symptoms; "covert" CNS damage that lacks symptoms but is recognized on brain imaging; and neurologic dysfunction without detectable injury, such as slurred speech or temporary weakness.The paper arises from concerns over a growing body of literature about these "covert" brain injuries following transcatheter aortic valve replacement (TAVR) and other cardiac procedures, researchers said. Co-author Michael Mack, MD, of Baylor Scott & White Health in Dallas, Tex., noted in a statement that until now, "many studies evaluating the safety of TAVR and other cardiovascular procedures only recorded the most devastating strokes, which meant that doctors – and their patients – were unaware of the full risk potential. We hope this paper will cause researchers to report their findings in a more comprehensive and consistent way so that clinicians can properly interpret the results to provide the best care to patients." Mack was a principal investigator in the pivotal PARTNER trials of the Sapien valve.
The consensus paper, developed by the Neurologic Academic Research Consortium (NeuroARC), was published in the Journal of the American College of Cardiology and European Heart Journal.
No comments:
Post a Comment